FRI-363 - Comparison of event-free survival between DAA and IFN-based antiviral therapy for HCV, adjusted for disease severity
| Autor: | Krassenburg, L., Zanjir, W.R., Georgie, F., Munawar, K., Cerocchi, O., Stotland, E., Lau, J., Janssen, H., Hansen, B., Feld, J. |
|---|---|
| Zdroj: | In Journal of Hepatology April 2018 68 Supplement 1:S526-S527 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|
Full Text from ScienceDirect